Clinical Study With Berberine-based Food Supplement, Artichoke Extract, Phytosterols, Fenugreek and SelectSIEVE® OptiChol
PARAF
1 other identifier
interventional
36
1 country
1
Brief Summary
To evaluate the effects of a nutraceutical containing Berberine-based Food Supplement, Artichoke Extract, Phytosterols, Fenugreek and SelectSIEVE® OptiChol on lipid profile
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 23, 2024
CompletedFirst Posted
Study publicly available on registry
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedApril 1, 2024
March 1, 2024
9 months
March 23, 2024
March 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Variations of lipid profile
12 weeks
Study Arms (2)
1 tablet
EXPERIMENTAL2 tablets
ACTIVE COMPARATORInterventions
Patients will take 1 tablet of Berberine-based Food Supplement, Artichoke Extract, Phytosterols, Fenugreek and SelectSIEVE® OptiChol for 12 weeks
Eligibility Criteria
You may qualify if:
- LDL Cholesterol \> 115 mg/dl and \< 190 mg/dl
- primary prevention
You may not qualify if:
- patients with neoplastic and liver diseases, renal failure and diabetes mellitus
- pregnant or breastfeeding women
- hypersensitivity to any of the ingredients
- therapy with lipid-lowering drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Policlinico S. Matteo Foundation
Pavia, 27100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 23, 2024
First Posted
April 1, 2024
Study Start
June 7, 2023
Primary Completion
March 1, 2024
Study Completion
May 1, 2024
Last Updated
April 1, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share